445 filings
Page 6 of 23
UPLOAD
lidge7vsnxo35tdff3
7 Sep 22
Letter from SEC
12:00am
SC 13G/A
ztrmgx8l5 hwha1abi1
6 Sep 22
MESOBLAST / M&G INVESTMENT MANAGEMENT ownership change
3:19pm
F-3
hy0by2225m17g k2drbe
31 Aug 22
Shelf registration (foreign)
8:35am
6-K
2jtlfed0aj5s41ik
31 Aug 22
Current report (foreign)
6:36am
6-K
j5a9 emt1
19 Aug 22
Jane Bell Joins Mesoblast Board
8:52pm
6-K
bxu zywjte
16 Aug 22
Mesoblast Completes US$45 Million Private Placement to Major Shareholders
7:38am
6-K
7zg7i
5 Aug 22
Appendix 4C Quarterly Activity Report
6:26am
6-K
4wo7u5qc7dm7 11
20 Jul 22
Current report (foreign)
8:20pm
6-K
c9vzpy x1xah
14 Jul 22
Rexlemestrocel-l to Be Highlighted at Maxim’s Panel on Late-stage Advancements In Heart Failure Therapeutics and Management
4:00pm
6-K
l96h08sr iuf7osath
17 Jun 22
Current report (foreign)
6:01am
6-K
nu7b3wd
3 Jun 22
Current report (foreign)
9:26am
6-K
hswx8si
2 Jun 22
Current report (foreign)
7:50pm
6-K
faf64
23 May 22
Current report (foreign)
6:02am
6-K
mp3pqwf9ywbwg0ykuvc
2 May 22
Appendix 4C Quarterly Activity Report
8:31pm
6-K
r2bg3bo rcf
20 Apr 22
Current report (foreign)
6:02am
6-K
moy 6x6g6uu
11 Apr 22
Appointment of Joint Company Secretary
6:00am
SC 13G/A
dxo16i67iof v05g9j7
8 Apr 22
MESOBLAST / M&G INVESTMENT MANAGEMENT ownership change
1:07pm
6-K
wosnfq
30 Mar 22
Philip R. Krause, M.D., Former Fda Deputy Chief for Vaccines, Joins Mesoblast Board
7:52am
6-K
o84f wdhc
28 Feb 22
Current report (foreign)
8:14pm